Price to Earnings (P/E)
since 2005
Paying user area
Try for free
Abiomed Inc. pages available for free this week:
- Cash Flow Statement
- Common-Size Balance Sheet: Assets
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abiomed Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Abiomed Inc., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income (loss)1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | = | ÷ | = | ÷ | |||||||
| May 21, 2021 | = | ÷ | = | ÷ | |||||||
| May 21, 2020 | = | ÷ | = | ÷ | |||||||
| May 23, 2019 | = | ÷ | = | ÷ | |||||||
| May 24, 2018 | = | ÷ | = | ÷ | |||||||
| May 25, 2017 | = | ÷ | = | ÷ | |||||||
| May 26, 2016 | = | ÷ | = | ÷ | |||||||
| May 28, 2015 | = | ÷ | = | ÷ | |||||||
| May 28, 2014 | = | ÷ | = | ÷ | |||||||
| May 28, 2013 | = | ÷ | = | ÷ | |||||||
| Jun 4, 2012 | = | ÷ | = | ÷ | |||||||
| Jun 2, 2011 | = | ÷ | = | ÷ | |||||||
| Jun 8, 2010 | = | ÷ | = | ÷ | |||||||
| Jun 8, 2009 | = | ÷ | = | ÷ | |||||||
| Jun 16, 2008 | = | ÷ | = | ÷ | |||||||
| Jun 13, 2007 | = | ÷ | = | ÷ | |||||||
| Jun 14, 2006 | = | ÷ | = | ÷ | |||||||
| Jun 14, 2005 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Abiomed Inc. Annual Report.
The financial data reveals notable developments in share price, earnings per share (EPS), and price-to-earnings (P/E) ratios over the seventeen-year period under review.
- Share Price
- The share price demonstrates considerable volatility with an overall upward trajectory. Initial years show moderate fluctuations between approximately $7.43 and $22.17 until 2014. From 2014 onward, a significant increase is observed, peaking notably in 2018 at $394.46. Following this peak, the share price declined substantially, settling around $235.75 by 2022. This pattern indicates periods of both rapid investor optimism and subsequent corrections.
- Earnings Per Share (EPS)
- EPS figures indicate a transition from consistent losses in earlier years (2005-2007) toward profitability starting around 2011. The early financial difficulties are evidenced by negative EPS values reaching as low as -$1.24. A positive EPS emerges in 2012 and generally trends upward with some fluctuations. Significant increases are observed in 2015 at $2.72 and in 2019 at $5.74, illustrating improved operational performance. However, the most recent years show a slight decrease, declining to $3.00 by 2022.
- Price-to-Earnings (P/E) Ratio
- The P/E ratio is absent in early periods due to negative or negligible earnings. From 2013 onwards, it becomes available and varies widely. Initially, the P/E is very high, for example, 520.81 in 2013, reflecting low earnings relative to share price. Subsequent years feature fluctuations between roughly 22 and 156, indicating varying investor expectations and market sentiments. The P/E ratio remains elevated throughout, which may suggest high investor confidence in future growth despite earnings volatility.
In summary, the data depicts an evolution from an unprofitable phase with low and volatile share prices toward a phase characterized by substantial growth in share price and earnings, albeit accompanied by considerable valuation fluctuations. The high and volatile P/E ratios in later years emphasize speculative components or anticipated future growth embedded in the market valuation.
Comparison to Competitors
Abiomed Inc., P/E, long-term trends, comparison to competitors
| Abiomed Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| May 20, 2022 | ||||||
| May 21, 2021 | ||||||
| May 21, 2020 | ||||||
| May 23, 2019 | ||||||
| May 24, 2018 | ||||||
| May 25, 2017 | ||||||
| May 26, 2016 | ||||||
| May 28, 2015 | ||||||
| May 28, 2014 | ||||||
| May 28, 2013 | ||||||
| Jun 4, 2012 | ||||||
| Jun 2, 2011 | ||||||
| Jun 8, 2010 | ||||||
| Jun 8, 2009 | ||||||
| Jun 16, 2008 | ||||||
| Jun 13, 2007 | ||||||
| Jun 14, 2006 | ||||||
| Jun 14, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Sector (Health Care Equipment & Services)
Abiomed Inc., P/E, long-term trends, comparison to sector (health care equipment & services)
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| May 20, 2022 | ||
| May 21, 2021 | ||
| May 21, 2020 | ||
| May 23, 2019 | ||
| May 24, 2018 | ||
| May 25, 2017 | ||
| May 26, 2016 | ||
| May 28, 2015 | ||
| May 28, 2014 | ||
| May 28, 2013 | ||
| Jun 4, 2012 | ||
| Jun 2, 2011 | ||
| Jun 8, 2010 | ||
| Jun 8, 2009 | ||
| Jun 16, 2008 | ||
| Jun 13, 2007 | ||
| Jun 14, 2006 | ||
| Jun 14, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Industry (Health Care)
Abiomed Inc., P/E, long-term trends, comparison to industry (health care)
| Abiomed Inc. | Health Care | |
|---|---|---|
| May 20, 2022 | ||
| May 21, 2021 | ||
| May 21, 2020 | ||
| May 23, 2019 | ||
| May 24, 2018 | ||
| May 25, 2017 | ||
| May 26, 2016 | ||
| May 28, 2015 | ||
| May 28, 2014 | ||
| May 28, 2013 | ||
| Jun 4, 2012 | ||
| Jun 2, 2011 | ||
| Jun 8, 2010 | ||
| Jun 8, 2009 | ||
| Jun 16, 2008 | ||
| Jun 13, 2007 | ||
| Jun 14, 2006 | ||
| Jun 14, 2005 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).